Skip to main content

. 1968 Apr 27;2(5599):213–214. doi: 10.1136/bmj.2.5599.213

Cardiac failure in patients with valvar heart disease after use of propranolol to control atrial fibrillation.

N Conway, J Seymour, A Gelson

PMCID: PMC1985900 PMID: 5653028

206-4

Images in this article

Fig. 6a b c
on p.206-4

Fig. 6d
on p.206-4

Fig. 1
on p.206-4

Fig. 2
on p.206-4

Fig. 3
on p.206-4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Besterman E. M., Friedlander D. H. Clinical experiences with propranolol. Postgrad Med J. 1965 Sep;41(479):526–535. doi: 10.1136/pgmj.41.479.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
GAFFNEY T. E., BRAUNWALD E. Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. Am J Med. 1963 Mar;34:320–324. doi: 10.1016/0002-9343(63)90118-9. [DOI] [PubMed] [Google Scholar]
LEVY J. V., RICHARDS V. INOTROPIC EFFECTS OF OUABAIN ON RABBIT LEFT ATRIA IN PRESENCE OF BETA-ADRENERGIC BLOCKING DRUGS. Proc Soc Exp Biol Med. 1965 May;119:278–281. doi: 10.3181/00379727-119-30158. [DOI] [PubMed] [Google Scholar]
ROWLANDS D. J., HOWITT G., MARKMAN P. PROPRANOLOL (INDERAL) IN DISTURBANCES OF CARDIAC RHYTHM. Br Med J. 1965 Apr 3;1(5439):891–894. doi: 10.1136/bmj.1.5439.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
Stephen S. A. Unwanted effects of propranolol. Am J Cardiol. 1966 Sep;18(3):463–472. doi: 10.1016/0002-9149(66)90071-3. [DOI] [PubMed] [Google Scholar]
Stock J. P. Beta adrenergic blocking drugs in the clinical management of cardiac arrhythmias. Am J Cardiol. 1966 Sep;18(3):444–449. doi: 10.1016/0002-9149(66)90068-3. [DOI] [PubMed] [Google Scholar]
Szekely P., Jackson F., Wynne N. A., Vohra J. K., Batson G. A., Dow W. I. Clinical observations on the use of propranolol in disorders of cardiac rhythm. Am J Cardiol. 1966 Sep;18(3):426–430. doi: 10.1016/0002-9149(66)90065-8. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES